EDUARDO DÍAZ-RUBIO GARCÍA-rekin lankidetzan egindako argitalpenak (12)

2022

  1. Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets

    Cancers, Vol. 14, Núm. 21

2020

  1. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1

2019

  1. Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

    Nature Communications, Vol. 9, Núm. 1

2017

  1. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable CT3-4 or N+ rectal cancer: Five-year disease-free survival results of a single-center series

    Clinical Colorectal Cancer, Vol. 15, Núm. 2, pp. 128-134

2015

  1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338

2014

  1. Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394

2012

  1. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

    BMC Cancer, Vol. 12

2011

  1. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine- radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer

    Anti-Cancer Drugs, Vol. 22, Núm. 2, pp. 185-190

2005

  1. Epididymal metastases as the first sign of a colon cancer recurrence

    Clinical and Translational Oncology, Vol. 7, Núm. 7, pp. 321-323

1998

  1. End-stage acute hepatic failure as clinical presentation of liver metastases from breast cancer

    Tumori, Vol. 84, Núm. 5, pp. 616-617